From: NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users
n | % | |
---|---|---|
Median age, years (min max) | 40 (24–57) | |
Sex | ||
Male | 30 | 91 |
Female | 2 | 6 |
Other (unspecified) | 1 | 3 |
Education | ||
Graduate degree | 19 | |
High school diploma | 9 | |
Less than high school diploma | 5 | |
Work situation | ||
Employed | 19 | |
Unemployed | 12 | |
Unknown | 2 | |
Lifetime self-report drug use (n = 23) | ||
Alcohol | 16 | 69.9 |
Cannabis | 15 | 65.2 |
Cocaine | 9 | 39.1 |
Hallucinogens | 11 | 47.8 |
Amphetamine | 15 | 65.2 |
Others | 15 | 65.2 |
Opiates | 11 | 47.8 |
3-MMC consumption frequency | ||
More than 10 per month | 12 | |
More than 10 per year | 14 | |
Less than 10 per year | 6 | |
Never | 1 | |
Routes of administration | ||
Snorting | 19 | 57.6 |
Injection | 5 | 15.2 |
Oral | 20 | 60.6 |
Rectal | 4 | 12.1 |
Desired effects | ||
Sex enhancement | 26 | 78.8 |
Sociability | 15 | 45.5 |
Getting high | 15 | 45.5 |
Stimulation | 12 | 36.4 |
Perception modification | 7 | 21.2 |
Anxiolysis | 6 | 18.2 |
Relaxation | 5 | 15.2 |
Pain release | 3 | 9.1 |
Intellectual stimulation | 2 | 6.1 |